HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 60 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,223,897 | +0.2% | 1,227,461 | +7.6% | 0.00% | 0.0% |
| Q2 2023 | $40,149,467 | +17.8% | 1,140,934 | +9.3% | 0.00% | 0.0% |
| Q1 2023 | $34,073,442 | -68.2% | 1,043,597 | -46.4% | 0.00% | -33.3% |
| Q4 2022 | $107,200,686 | +124.8% | 1,945,566 | +80.7% | 0.00% | 0.0% |
| Q3 2022 | $47,693,000 | +3.6% | 1,076,826 | +14.0% | 0.00% | 0.0% |
| Q2 2022 | $46,055,000 | +14.3% | 944,335 | +14.0% | 0.00% | +50.0% |
| Q1 2022 | $40,291,000 | +21.8% | 828,181 | +6.8% | 0.00% | 0.0% |
| Q4 2021 | $33,075,000 | +117.4% | 775,683 | +95.5% | 0.00% | +100.0% |
| Q3 2021 | $15,212,000 | +78.0% | 396,858 | +31.1% | 0.00% | – |
| Q2 2021 | $8,548,000 | +195.8% | 302,790 | +246.1% | 0.00% | – |
| Q1 2021 | $2,890,000 | -3.4% | 87,478 | +5.7% | 0.00% | – |
| Q4 2020 | $2,992,000 | – | 82,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |